Condition: Ulcerative Colitis · Sponsor: Janssen Research & Development, LLC
The purpose of this study is to evaluate the efficacy and safety of guselkumab in participants with moderately to severely active ulcerative colitis (UC).
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Om Research LLC | Lancaster, California, United States | — |
| UCLA | Los Angeles, California, United States | — |
| Peak Gastroenterology Associates 1 | Colorado Springs, Colorado, United States | — |
| Florida Research Network, LLC | Gainesville, Florida, United States | — |
| University of Florida Health Jacksonville | Gainesville, Florida, United States | — |
| Harmony Medical Research Institute, Inc. | Hialeah, Florida, United States | — |
| UF Health Jacksonville Gastroenterology Emerson | Jacksonville, Florida, United States | — |
| I.H.S. Health. LLC | Kissimmee, Florida, United States | — |
| Columbus Clinical Services LLC | Miami, Florida, United States | — |
| Vista Health Research, LLC | Miami, Florida, United States | — |
| Orlando Health | Orlando, Florida, United States | — |
| Care Access Research, Orlando | Orlando, Florida, United States | — |
+ 380 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.